CAVIN2 p.Ser35Arg
c.103A>C · VCV3995916
Computational evidence
| Protein change | ||
| AlphaMissense | 0.674 | likely pathogenic |
|---|---|---|
| REVEL | 0.137 | moderately benign-leaning |
| SaProt | LLR -9.64 | tolerated |
| ⇒ AlphaMissense calls this damaging; REVEL and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6 | GERP 0.88, phastCons 1 |
| Regional constraint | o/e 1.01 | unconstrained · MANE · 11 kb · p 0.79 · regional, not allelic |
| Overall | ||
| CADD | 21.5 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00373% | 26,819 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,510 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CAVIN2
- Protein
- p.Ser35Arg
- Coding
- c.103A>C
- MANE Select
- NM_004657
- Type
- single nucleotide variant
- Location
- chr2:191846823 (GRCh38)
- Gene constraint
- LOEUF 1.593 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 63.48
- Residue 35
- a modified residue (phosphoserine); the 'disordered' region; the 'interaction with cavin1' region
Similar variants
- CAVIN2 p.Lys173= Benign ★★ same type
- CAVIN2 p.Val66= Benign ★★ same type
- CAVIN2 p.Ala105Asp Uncertain significance ★ ⚠ same type
- CAVIN2 p.Ala137Val Uncertain significance ★ ⚠ same type
- CAVIN2 p.Ala309Thr Uncertain significance ★ ⚠ same type
- CAVIN2 p.Ala400Thr Uncertain significance ★ ⚠ same type
- CAVIN2 p.Arg131His Uncertain significance ★ ⚠ same type
- CAVIN2 p.Arg141Pro Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cavin2-p-ser35arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown